C. D. du Toit

Combined submyeloablative and myeloablative dose intense melphalan results in satisfactory responses with acceptable toxicity in patients with multiple myeloma.

N. Novitzky, J. Thomson, V. Thomas, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Is there a role for autologous stem cell transplantation for patients with acute myelogenous leukemia? A retrospective analysis.

N. Novitzky, V. Thomas, C. D. du Toit, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Thrombotic thrombocytopenic purpura in patients with retroviral infection is highly responsive to plasma infusion therapy

J. Thomson, N. Novitzky, C. D. du Toit, 2005, British journal of haematology.

Increased apoptosis of bone marrow cells and preserved proliferative capacity of selected progenitors predict for clinical response to anti-inflammatory therapy in myelodysplastic syndromes.

J. Finlayson, N. Novitzky, C. D. du Toit, 2000, Experimental hematology.

Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT)

A. Gratwohl, D. Niederwieser, J. Hermans, 2002, British journal of haematology.

Predictors of poor haematopoietic stem cell mobilisation in patients with haematological malignancies at a South African centre.

J. D. du Toit, E. Verburgh, M. Seftel, 2022, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Prevention of graft vs. host disease with alemtuzumab 'in the bag' decreases early toxicity of stem cell transplantation and in multiple myeloma is associated with improved long-term outcome.

N. Novitzky, V. Thomas, C. D. du Toit, 2008, Cytotherapy.

In stem cell transplantation, by limiting the morbidity of graft-versus-host disease tolerance to myeloablative conditioning is improved.

N. Novitzky, V. Thomas, C. D. du Toit, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Conditioning with purine analogs leads to good engraftment rates of immunodepleted grafts for aplastic anemia.

N. Novitzky, V. Thomas, C. D. du Toit, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia

N. Novitzky, V. Thomas, C. D. du Toit, 2004, American journal of hematology.

Bone marrow transplantation depleted of T cells followed by repletion with incremental doses of donor lymphocytes for relapsing patients with chronic myeloid leukemia: a therapeutic strategy.

N. Novitzky, V. Thomas, C. D. du Toit, 2000, Transplantation.

The International Prognostic Score and HIV status predict red cell concentrate transfusion needs in Hodgkin lymphoma

J. Opie, E. Verburgh, V. Louw, 2022, Leukemia & lymphoma.

MULTIPLE MYELOMA: INFUSIONS OF LOW DOSES OF DONOR LYMPHOCYTES ARE ALSO EFFECTIVE IN REVERSING DISEASE RECURRENCE AFTER BONE MARROW TRANSPLANTATION

N. Novitzky, C. D. du Toit, 1998, British journal of haematology.